Full-Time

Senior Program Manager

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

In Person

Travel ~25% to domestic and international suppliers.

Bachelor's, Master's

Category
Business & Strategy (1)
Required Skills
Forecasting
Risk Management
Excel/Numbers/Sheets
Financial Modeling
PowerPoint/Keynote/Slides

Get referred to Intuitive Surgical

See people who can refer or advise you

Requirements
  • Significant experience with new product introduction (NPI) in a regulated manufacturing environment
  • Exceptional negotiation skills, proven track record of savings, and history of successful contract negotiations
  • Significant computer experience including MS Office products and ERP systems. Strong Excel & PowerPoint skills
  • Proven track record of effective project management in a fast-paced manufacturing company. Ability to handle multiple tasks and projects successfully and adapt to changing priorities
  • Strong financial acumen; excellent working knowledge of corporate/production finance; experience building financial models and using financial knowledge to understand supplier operations
  • Working knowledge of buying, material planning, master scheduling, and forecasting
  • Presentation skills and the ability to make complex topics simple to drive decision making
  • Demonstrates concern for precision and thoroughness
  • Proven ability to consistently achieve stretch goals and objectives
  • Excellent verbal and written communication skills; experience presenting to senior leadership
  • BS degree or equivalent and 15+ years of combined design engineering, manufacturing engineering, industrial engineering, manufacturing operations, and/or supply chain experience, including at least 8 years of supply chain experience and 3 years of engineering experience, in a regulated industry manufacturing environment. Master’s degree preferred.
  • ~25% travel to both domestic and international suppliers
Responsibilities
  • New Product Program Leadership & Category Management: Provides cross-functional team leadership within assigned new product program(s) of highest complexity; leads cross functional program updates, executive reviews, and alignment forums.
  • Leads creation, management, and execution of program roadmaps to achieve cost, capacity, speed to market, and risk contract goals.
  • Provides cross-functional team leadership within assigned category(ies) of highest complexity; leads cross-functional category team meetings
  • Leads creation of long-term supplier strategies and roadmaps; able to navigate complex trade-offs in supplier strategies. Effectively influences broader organization through expert requirements gathering and leading adoption of developed strategies.
  • Co-leads direct procurement supplier selection process with collaboration from Supplier Engineering. Expertly and independently deploys strategic sourcing practices to identify a core supply base able to offer lowest total cost of ownership and high-quality product while identifying value improvement opportunities.
  • Supplier Performance Management: Proactively collaborates with supply base and procurement team to understand and communicate demand changes and minimize excess inventory or material shortages during program development. Able to expertly translate business shifts and design changes to suppliers and effectively understand root cause of demand changes internally.
  • Collaborate with strategic sourcing teams on shared supplier performance escalations, lead supplier escalations for new suppliers to support NPI program deliverables.
  • Effectively escalates for issue resolution with supplier executive leadership. Possesses executive presence and awareness and able to drive problem resolution onsite at suppliers.
  • Risk and Capacity Management: Develops high complexity mitigation plans and programs for assigned suppliers and critical sub-tier suppliers; implements plans when applicable
  • Leads capacity assessments for assigned suppliers and critical sub-tier suppliers; operating on three-to-five-year horizon for capacity strategies for global category and able to marshal support for proactive mitigations
  • May serve as project manager for key supplier capacity or risk mitigation initiatives
  • Leverages problem solving skills and develops counter-measures to implement long-term solutions to identified problems
  • Contract and Cost Management: Expert contract and cost negotiator; independently establishes contractual agreements with suppliers and amendments to existing agreements. Develops new contract language and templates as required.
  • Negotiates long-term commercial agreements with executive leadership of suppliers. Installs development, cost, scale, risk mitigation and capacity agreements with key suppliers to support Intuitive’s new product introductions & volume growth.
  • Leads identification and implementation of cost reduction ideas to achieve program contract cost goals.
  • Acts as key thought leader within the Global Supply Chain organization through monitoring of industry and profession trends, determining, influencing, and implementing needed process improvements, and mentoring colleagues throughout the supply chain organization.
Desired Qualifications
  • Experience in the medical device industry or regulated manufacturing preferred.
  • SAP and Agile experience preferred.
  • Experience managing spend/suppliers and/or technical expertise in the following categories preferred, metals (CNC machining, aluminum castings), rapid prototyping technologies, or motion control (motors, brakes, sensors).
  • Experience utilizing strategic sourcing principles, including six step sourcing process, category strategy development and adoption, and collaborative supplier management
  • Certifications: CPSM, CPIM, and/or PMP preferred.
  • Ability to read and have a basic understanding of engineering drawings preferred
  • Basic understanding of data visualization tools (similar to Tableau, Power BI etc.) preferred
  • Experience with make vs. buy decisions & ROI analysis preferred
  • Knowledge of Cost of Goods Sold (COGs) and cost levers preferred

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 19% to $2.89 billion, beating estimates again.
  • Intuitive raised 2026 da Vinci procedure growth guidance to 13.5%-15.5%.
  • Asia-Pacific demand supports Penang operations starting 2028 and 1,200 jobs by 2032.

What critics are saying

  • FDA Class II recalls in 2026 hit da Vinci X, Xi, and SP components.
  • US da Vinci growth slowed to 12% in Q2 2026, signaling elective-procedure deferral.
  • Medtronic's Hugo and other robotic entrants erode Intuitive's pricing power by 2027.

What makes Intuitive Surgical unique

  • Da Vinci 5 deepens Intuitive Surgical's installed-base moat; Q2 2026 placements hit 468.
  • Recurring instruments and accessories drove 85% of Q2 2026 revenue, stabilizing cash generation.
  • Penang facility in Malaysia expands manufacturing resilience for da Vinci instruments and electromechanical devices.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 23rd, 2026
Thermo Fisher vs Intuitive Surgical: which premium healthcare stock justifies valuation?

Thermo Fisher and Intuitive Surgical both delivered strong recent quarters, but their premium valuations rest on different foundations. Thermo Fisher's case depends on recovery in life sciences spending after the pandemic slowdown. The company's Life Sciences Solutions segment saw reported revenue climb 13% year-over-year, with organic revenue up 3%. The Analytical Instruments business returned to growth after nearly two years of weak demand, suggesting laboratory spending is normalising. Intuitive Surgical maintains its premium through business model strength. The company's non-GAAP gross profit margin reached 70.0%, whilst its non-GAAP operating margin expanded 330 basis points year-over-year to 42.1%. Recurring revenue streams constitute roughly 85% of total sales. Intuitive placed 468 da Vinci surgical units in fiscal Q2, marking 18% year-over-year growth, indicating continued hospital investment in robotic surgery platforms.

Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.

Yahoo Finance
Aug 16th, 2026
Oppenheimer upgrades Intuitive Surgical to 'Outperform' with $500 price target

Oppenheimer upgraded Intuitive Surgical from "Perform" to "Outperform" with a $500 price target, implying a 24.6% upside. The analysts expect the medtech company to maintain its leading position in robotic surgery despite increasing competition. Intuitive reported strong Q2 results, with revenue rising 18.5% year-over-year to $2.89 billion, surpassing analyst expectations. Non-GAAP earnings per share climbed 27.9% to $2.80, beating the $2.50 estimate. The company placed 468 da Vinci surgical systems and 55 Ion endoluminal systems during the quarter. Combined da Vinci and Ion procedures rose approximately 16% globally. Wall Street maintains a "Strong Buy" consensus rating on the stock, with 22 of 31 analysts recommending a strong buy. The consensus price target of $480.93 represents a 19.85% upside.

Yahoo Finance
Aug 12th, 2026
Intuitive Surgical's valuation barely budges despite two years of growth forecasts

Intuitive Surgical trades at $401.23, down 32% from its 52-week high and 15% over twelve months. The stock currently trades at 37.7 times trailing adjusted earnings. Analysts forecast earnings of $12.08 per share by 2027, bringing the multiple down to 33 times — only 13% lower despite two years of growth. Consensus projects 7% annual earnings growth and 9.7% revenue growth, suggesting margin compression ahead. Management raised its 2026 gross profit margin guidance to 68-69%. However, the company plans to extend instrument use limits starting in the first half of 2027 to lower procedure costs and boost adoption. Intuitive has not finalised pricing for this programme, creating uncertainty around 2027 estimates. The company will quantify the impact on its next earnings call.